This paper is in the following e-collection/theme issue:

Usability of Apps and User Perceptions of mHealth (974) Immunology, Allergy, Rheumatology (89) Caregiving and Parenting for Chronic Pediatric Diseases (82)

Published on in Vol 7, No 8 (2019): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13414, first published .
Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study

Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study

Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study

Authors of this article:

Michal Gaziel Yablowitz1 Author Orcid Image ;   Sabine Dölle2 Author Orcid Image ;   David G Schwartz1 Author Orcid Image ;   Margitta Worm2 Author Orcid Image
Article Authors Cited by (11) Tweetations (1) Metrics

Journals

  1. Marcu G, Aizen R, Roth A, Lankenau S, Schwartz D. Acceptability of smartphone applications for facilitating layperson naloxone administration during opioid overdoses. JAMIA Open 2020;3(1):44 View
  2. Maris I, Dölle‐Bierke S, Renaudin J, Lange L, Koehli A, Spindler T, Hourihane J, Scherer K, Nemat K, Kemen C, Neustädter I, Vogelberg C, Reese T, Yildiz I, Szepfalusi Z, Ott H, Straube H, Papadopoulos N, Hämmerling S, Staden U, Polz M, Mustakov T, Cichocka‐Jarosz E, Cocco R, Fiocchi A, Fernandez‐Rivas M, Worm M. Peanut‐induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry. Allergy 2021;76(5):1517 View
  3. Shaker M, Turner P, Greenhawt M. A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy—One Epinephrine Autoinjector or Two?. The Journal of Allergy and Clinical Immunology: In Practice 2021;9(6):2440 View
  4. Ataiants J, Reed M, Schwartz D, Roth A, Marcu G, Lankenau S. Decision-making by laypersons equipped with an emergency response smartphone app for opioid overdose. International Journal of Drug Policy 2021;95:103250 View
  5. Anto A, Sousa-Pinto B, Bousquet J. Anaphylaxis and digital medicine. Current Opinion in Allergy & Clinical Immunology 2021;21(5):448 View
  6. Dribin T, Waserman S, Turner P. Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes. The Journal of Allergy and Clinical Immunology: In Practice 2023;11(4):1036 View
  7. Höfer V, Martini M, Dölle‐Bierke S, Worm M, Bilò M. Health‐related quality of life in food and venom induced anaphylaxis and role of influencing factors. Clinical & Experimental Allergy 2023;53(3):295 View
  8. Stiles S, Roche I, Said M, Clifford R, Sanfilippo F, Loh R, Salter S. Overview of registries for anaphylaxis: a scoping review. JBI Evidence Synthesis 2022;20(11):2656 View
  9. Van Baelen F, De Regge M, Larivière B, Verleye K, Schelfout S, Eeckloo K. Role of Social and App-Related Factors in Behavioral Engagement With mHealth for Improved Well-being Among Chronically Ill Patients: Scenario-Based Survey Study. JMIR mHealth and uHealth 2022;10(8):e33772 View
  10. Golden D, Wang J, Waserman S, Akin C, Campbell R, Ellis A, Greenhawt M, Lang D, Ledford D, Lieberman J, Oppenheimer J, Shaker M, Wallace D, Abrams E, Bernstein J, Chu D, Horner C, Rank M, Stukus D, Burrows A, Cruickshank H, Golden D. Anaphylaxis: A 2023 practice parameter update. Annals of Allergy, Asthma & Immunology 2024;132(2):124 View